腫瘍死滅因子は,c-myc発現を減少させ,HeLa細胞のインターフェロン-ガンマと協力する
まとめ
腫瘍死滅因子 (TNF) とインターフェロン-ガンマ (IFN-ガンマ) は,HeLa細胞におけるc-myc腫瘍遺伝子の発現を阻害する. これらのサイトカインは,異なる分子経路を通じて細胞の成長を抑制し,潜在的な治療的影響を及ぼします.
科学分野:
- 分子生物学は分子生物学である.
- 細胞サイクル調節 細胞サイクル調節
- 腫瘍遺伝子の研究
背景:
- c-myc腫瘍遺伝子は細胞増殖に重要な役割を果たしています.
- 自然に発生する成長阻害剤は,c-myc発現を制御すると仮定されています.
- TNFやIFN-ガンマのようなサイトカインは,細胞サイクル停止を誘発する.
研究 の 目的:
- HeLa細胞におけるc-myc発現に対するTNFとIFN-ガンマの影響を調査する.
- サイトカイン媒介によるc-myc抑制の基礎となる分子メカニズムを解明する.
- TNFとIFN-ガンマが連携して作用するか,独立して作用するかどうかを判断する.
主な方法:
- HeLa細胞はTNFおよび/またはIFN-ガンマで治療された.
- ノーザンブロット分析は,c-mycメッセンジャーRNA (mRNA) レベルを定量化するために使用されました.
- 核転写アッセイは,c-myc遺伝子転写の速度を評価した.
- 実験には,タンパク質合成依存性を評価するためにサイクロヘキシミドの使用が含まれていました.
主要な成果:
- TNFとIFN-ガンマの両方が,転写抑制を介して1〜3時間以内にc-myc mRNAレベルを著しく低下させた.
- TNFとIFN-ガンマを併用した治療は,c-myc転写とmRNAレベルの抑制を強めた.
- IFN-ガンマの効果には新しいタンパク質合成が必要で,TNFの効果は直接的で,サイクロヘキシミドに耐性がある.
- タンパク質合成の阻害と相乗効果に対する異なる反応は,異なる分子メカニズムを示唆する.
結論:
- TNFとIFN-ガンマはHeLa細胞におけるc-myc腫瘍遺伝子の転写を効果的に抑制する.
- サイトカインは,c-myc発現を阻害する際には,明確な分子メカニズムを示しています.
- 協力的阻害は,がんにおけるc-mycを標的とした潜在的な治療戦略を示唆する.
さらに関連する動画
関連する概念動画
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


